{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:00:41Z","timestamp":1783702841647,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA247801"],"award-info":[{"award-number":["T32CA247801"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.hpb.2023.12.006","type":"journal-article","created":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T17:38:53Z","timestamp":1702489133000},"page":"656-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Safety and feasibility of establishing an adjuvant hepatic artery infusion program"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2721-3519","authenticated-orcid":false,"given":"Lauren M.","family":"Janczewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4120-1058","authenticated-orcid":false,"given":"Rachel H.","family":"Joung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir A.","family":"Borhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5510-788X","authenticated-orcid":false,"given":"Robert J.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-5727","authenticated-orcid":false,"given":"Yury S.","family":"Velichko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Mulcahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devalingam","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh N.","family":"Keswani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaliy Y.","family":"Poylin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Bentrem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Merkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2023.12.006_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5306\/wjco.v11.i10.761","article-title":"Colorectal liver metastases: current management and future perspectives","volume":"11","author":"Martin","year":"2020","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1477-7819-12-155","article-title":"Prognostic significance of the number of tumors and aggressive surgical approach in colorectal cancer hepatic metastasis","volume":"12","author":"Chan","year":"2014","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4174\/astr.2014.87.1.14","article-title":"Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases","volume":"87","author":"Park","year":"2014","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.hpb.2023.12.006_bib4","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1200\/JCO.2007.11.0833","article-title":"Actual 10-year survival after resection of colorectal liver metastases defines cure","volume":"25","author":"Tomlinson","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jamcollsurg.2020.11.013","article-title":"Getting chemotherapy directly to the liver: the historical evolution of hepatic artery chemotherapy","volume":"232","author":"Anteby","year":"2021","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.hpb.2023.12.006_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/PPO.0b013e3181d7ea51","article-title":"Implanted hepatic arterial infusion pumps","volume":"16","author":"Callahan","year":"2010","journal-title":"Cancer J"},{"key":"10.1016\/j.hpb.2023.12.006_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0002-9610(74)90161-5","article-title":"Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon","volume":"127","author":"Cady","year":"1974","journal-title":"Am J Surg"},{"key":"10.1016\/j.hpb.2023.12.006_bib8","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.3747\/co.21.1592","article-title":"Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era","volume":"21","author":"Ko","year":"2014","journal-title":"Curr Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/SLA.0000000000000614","article-title":"Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes","volume":"261","author":"D'Angelica","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.12.006_bib10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/jso.23204","article-title":"Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease","volume":"106","author":"Ammori","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1245\/s10434-016-5418-6","article-title":"Hepatic arterial infusion in combination with modern systemic chemotherapy is associated with improved survival compared with modern systemic chemotherapy alone in patients with isolated unresectable colorectal liver metastases: a case-control study","volume":"24","author":"Dhir","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/annonc\/mdv548","article-title":"Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV","volume":"27","author":"Levi","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib13","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJM199912303412702","article-title":"Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer","volume":"341","author":"Kemeny","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2023.12.006_bib14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/jso.24189","article-title":"Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy","volume":"113","author":"Kemeny","year":"2016","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib15","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1200\/JCO.2008.17.3781","article-title":"Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials","volume":"26","author":"Mitry","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib16","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/00000658-199812000-00006","article-title":"Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)","volume":"228","author":"Lorenz","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.12.006_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2005.03.019","article-title":"Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: an institutional experience of 544 consecutive cases","volume":"201","author":"Allen","year":"2005","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.hpb.2023.12.006_bib18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/SLA.0000000000005434","article-title":"Hepatic artery infusion pumps: a surgical toolkit for intraoperative decision-making and management of hepatic artery infusion-specific complications","volume":"276","author":"Sharib","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.12.006_bib19","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archsurg.1984.01390200054013","article-title":"Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity","volume":"119","author":"Daly","year":"1984","journal-title":"Arch Surg"},{"key":"10.1016\/j.hpb.2023.12.006_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jso.26270","article-title":"Safety and feasibility of initiating a hepatic artery infusion pump chemotherapy program for unresectable colorectal liver metastases: a multicenter, retrospective cohort study","volume":"123","author":"Muaddi","year":"2021","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib21","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.1245\/s10434-020-08972-y","article-title":"Implementation of a hepatic artery infusion program: initial patient selection and perioperative outcomes of concurrent hepatic artery infusion and systemic chemotherapy for colorectal liver metastases","volume":"27","author":"Creasy","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/jso.25249","article-title":"Implementation and early outcomes for a surgeon-directed hepatic arterial infusion pump program for colorectal liver metastases","volume":"118","author":"Chakedis","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib23","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1245\/s10434-019-07973-w","article-title":"Adjuvant hepatic arterial infusion pump chemotherapy after resection of colorectal liver metastases: results of a safety and feasibility study in The Netherlands","volume":"26","author":"Buisman","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.surg.2023.03.026","article-title":"Starting a successful hepatic artery infusion pump program: a practical guide","volume":"174","author":"McDonald","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.hpb.2023.12.006_bib25","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1245\/s10434-020-08938-0","article-title":"Short-term risk of performing concurrent procedures with hepatic artery infusion pump placement","volume":"27","author":"Brajcich","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(09)70330-4","article-title":"Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial","volume":"11","author":"Folprecht","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib27","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2005.03.8166","article-title":"Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)","volume":"24","author":"Kemeny","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jso.24898","article-title":"Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: long term results and curative potential","volume":"117","author":"Pak","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib29","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/annonc\/mdp029","article-title":"Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival","volume":"20","author":"Jarnagin","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jso.26911","article-title":"Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: outcomes in a newly established program","volume":"126","author":"Walker","year":"2022","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1245\/s10434-011-2102-8","article-title":"Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors","volume":"19","author":"Ito","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2023.12.006_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00000658-198508000-00007","article-title":"Sclerosing cholangitis after continuous hepatic artery infusion of FUDR","volume":"202","author":"Kemeny","year":"1985","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2023.12.006_bib33","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.hpb.2022.08.008","article-title":"Considerations and barriers to starting a new HAI pump program: an international survey of the HAI Consortium Research Network","volume":"24","author":"Cavnar","year":"2022","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2023.12.006_bib34","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.3747\/co.21.1577","article-title":"Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement","volume":"21","author":"Karanicolas","year":"2014","journal-title":"Curr Oncol"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X23020130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X23020130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T13:08:04Z","timestamp":1746104884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X23020130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1365182X23020130"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2023.12.006","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and feasibility of establishing an adjuvant hepatic artery infusion program","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2023.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}